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13 Abstract Receptors for purines and pyrimidines are
14 expressed throughout the cardiovascular system. This study
15 investigated their functional expression in porcine-isolated
16 pancreatic arteries. Pancreatic arteries (endothelium intact or
17 denuded) were prepared for isometric tension recording and
18 preconstricted with U46619, a thromboxane A2 mimetic;
19 adenosine-5′-diphosphate (ADP), uridine-5′-triphosphate
20 (UTP) and MRS2768, a selective P2Y2 agonist, were applied
21 cumulatively, while adenosine-5′-triphosphate (ATP) and αβ-
22 methylene-ATP (αβ-meATP) response curves were generated
23 from single concentrations per tissue segment. Antagonists/
24 enzyme inhibitors were applied prior to U46619 addition.
25 ATP, αβ-meATP, UTP and MRS2768 induced vasoconstric-
26 tion, with a potency order ofαβ-meATP >MRS2768 >ATP ≥
27 UTP. Contractions to ATP and αβ-meATP were blocked by
28 NF449, a selective P2X1 receptor antagonist. The contraction
29 induced by ATP, but not UTP, was followed by vasorelax-
30 ation. Endothelium removal and DUP 697, a cyclooxygenase-
31 2 inhibitor, had no significant effect on contraction to ATP but
32 attenuated that to UTP, indicating actions at distinct receptors.
33 MRS2578, a selective P2Y6 receptor antagonist, had no effect
34 on contractions to UTP. ADP induced endothelium-dependent
35 vasorelaxation which was inhibited by MRS2179, a selective
36 P2Y1 receptor antagonist, or SCH58261, a selective adeno-
37 sine A2A receptor antagonist. The contractions to ATP and
38 αβ-meATP were attributed to actions at P2X1 receptors on
39 the vascular smooth muscle, whereas it was shown for the first
40 time that UTP induced an endothelium-dependent vasocon-
41 striction which may involve P2Y2 and/or P2Y4 receptors. The
42 relaxation induced by ADP is mediated by P2Y1 and A2A
43adenosine receptors. Porcine pancreatic arteries appear to lack
44vasorelaxant P2Y2 and P2Y4 receptors.
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71Introduction
72The activities of both exocrine and endocrine cells of the
73pancreas are regulated by autonomic nerves (parasympathetic
74and sympathetic) as well as by hormones and autocrine and
75paracrine mediators. Although the exact mechanisms remain
76to be established, it is generally agreed that an increase in
77endocrine cell activity during hormone secretion corresponds
78with an increase in blood flow, to meet the metabolic demand.
79The role of exogenous purine and pyrimidine nucleotides in
80controlling the functions of endocrine and exocrine compo-
81nents of the pancreas are well described [1, 2], but little is
82known about their effects on pancreatic arterial
83vasocontractility.
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84 There are two main families of P2 purine and pyrimidine
85 receptors, ionotropic P2X and G protein-coupled P2Y recep-
86 tors. Molecular cloning has identified seven mammalian P2X
87 receptor subunits: P2X1, P2X2, P2X3, P2X4, P2X5, P2X6
88 and P2X7 [3], while eight mammalian P2Y receptors have
89 been identified: P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12,
90 P2Y13 and P2Y14 [4]. P2X receptors are activated by
91 adenosine-5′-triphosphate (ATP) and its stable, and conse-
92 quently more potent, analogue αβ-methylene-ATP (αβ-
93 meATP) [5, 6]. P2Y receptors can be divided on the basis of
94 their endogenous agonists into adenine nucleotide-preferring
95 (P2Y1, P2Y11, P2Y12 and P2Y13) receptors and uracil nucle-
96 otide or UDP-sugar-preferring (P2Y2, P2Y4, P2Y6 and
97 P2Y14) receptors [7]. Among the adenine nucleotide group,
98 the human P2Y11 receptor is selectively activated by ATP and
99 fails to respond to adenosine-5′-diphosphate (ADP) [8], al-
100 though the dog orthologue responds to both ADP and ATP
101 [9]. P2Y1, P2Y12 and P2Y13 receptors are activated by ADP,
102 with lower potency by ATP [10–13]. Among the uracil nucle-
103 otide or UDP-sugar receptors, P2Y2 is equally activated by
104 ATP and uridine-5′-triphosphate (UTP), while P2Y4 receptor
105 is highly selective for UTP over ATP [14]. The P2Y6 receptor
106 is activated by UDP and UTP, while the P2Y14 receptor is
107 activated by UDP and UDP-sugars [6, 15].
108 Within the pancreatic vasculature, P2X1, P2X2, P2Y1 and
109 P2Y2 receptors were detected by immunohistochemistry [16].
110 More than two decades ago, it was shown that P2X receptors
111 mediate pancreatic vasoconstriction, and P2Y receptors me-
112 diate vasodilatation in response to ATP [17], and subsequent
113 studies showed an additional involvement of contractile re-
114 ceptors sensitive to UTP (named P2U receptors) [18]. Purine
115 receptor subclassification has advanced significantly since
116 that time. A re-evaluation of purine receptors in the pancreatic
117 vasculature is clearly warranted. In the current study, we
118 describe the pharmacological characterisation of P2Y1 and
119 A2A receptor-mediated relaxatory responses, in addition to
120 P2X1, P2Y2 and P2Y4 receptor-mediated contractile re-
121 sponses of porcine-isolated pancreatic artery preparations.
122 P2Y2 and/or P2Y4 receptors appear to be expressed mainly
123 in endothelial cells, while P2X1 and A2A receptors appear to
124 be expressed in smooth muscle cells of the pancreatic arteries.
125 A preliminary account of some of these data has previously
126 been presented to the British Pharmacological Society [19].
127 Materials and methods
128 Tissue preparation
129 Pancreases from pigs (either sex, age less than 6 months, wt
130 ∼50 kg) were obtained on ice from a local abattoir (GWood&
131 Sons Ltd., Mansfield). A crude dissection was conducted to
132 isolate the porcine pancreatic arteries (greater pancreatic
133artery) which were located in the body of the pancreas. The
134vessels were dissected out and placed in Krebs–Henseleit
135buffer containing 2 % (w /v ) Ficoll (hydrophilic polysaccha-
136ride, type 70) and were refrigerated overnight at 4 °C. The
137next day, a fine dissection was performed on arteries, and the
138artery segments were cut into rings of about 0.5 cm in length
139and suspended in Krebs–Henseleit buffer (gassed, 95 % O2,
1405 % CO2).
141The endothelium of some arteries was removed by gently
142rubbing the innermost surface of the artery with forceps on a
143paper tissue before attaching it to the set-up [20]. Successful
144removal of the endothelium was tested using substance P
145(10 nM). Endothelium-denuded arteries relaxed in response
146to substance P to less than 10 % of the U46619-induced
147contraction, while in endothelium-intact arteries, the relaxa-
148tion to substance P was 36 %±8 (n =7, data not shown).
149Responses in the porcine-isolated pancreatic artery
150Arterial rings were mounted onto wires in tissue baths con-
151taining warm (37 °C), oxygenated Krebs–Henseleit solution
152and were connected via isometric force transducers
153(mechanotransducer MLT 050/D; ADInstruments, Sydney,
154Australia) to a PC running the computer programme,
155LabChart (ADInstruments, Sydney, Australia). Rings were
156put under tension (15 g) and allowed to equilibrate for
15760 min before assessing the viability with two challenges of
15875 mM potassium chloride (KCl). The tissues were then
159allowed to equilibrate for 60 min, after which U46619 (10–
160100 nM), a thromboxane A2 mimetic, was used to contract the
161tissues to between 40 and 80 % of the second KCl response.
162This ensured that if there was a vasodilator component to the
163response, this could be detected. Once an appropriate level of
164U46619 response had been achieved, ATP, αβ-meATP, UTP,
165ADP or MRS2768 were added. Antagonists or enzyme inhib-
166itors were applied 10 min prior to the addition of U46619,
167allowing them to be incubated with the tissues for a minimal
168contact time of 30 min prior to the application of agonists.
169Some arteries were incubated with 0.1 % (v /v ) DMSO (vehi-
170cle control).
171Reagents and drugs
172Krebs–Henseleit buffer was composed of the following (mM):
173NaCl, 118; KCl, 4.8; CaCl2·H2O, 1.3; NaHCO3, 25.0;
174KH2PO4, 1.2; MgSO4·7H2O, 1.2; and glucose, 11.1. Suramin,
175UTP, ATP, αβ-meATP, ADP, U46619, xanthine amine con-
176gener (XAC) and SCH58261 (7-(2-phenylethyl)-5-amino-
1772-(2-furyl)-pyrazolo-[4,3-e ]-1,2,4-triazolo[1,5-c ]pyrimidine)
178were purchased from Sigma (Poole, Dorset, UK), while DUP
1796 9 7 ( 5 - b r o m o - 2 - ( 4 - f l u o r o p h e n y l ) -
1803-[4-(me thylsulfonyl)phenyl]-thiophene), pyridoxal
181phosphate-6-azo(benzene-2,4-disulfonic acid) (PPADS),
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182 MRS2 5 7 8 (N ,N ″ - 1 , 4 - b u t a n e d i y l b i s (N ′ - [ 3 -
183 isothiocynatophenyl] thiourea)), MRS2179 (2′-deoxy-N 6-
184 methyladenosine 3′,5′-bisphosphate tetrasodium salt),
185 MRS2768 (uridine-5′-tetraphosphate δ -phenyl ester
186 tetrasodium salt) and substance P were purchased from Tocris
187 Biosciences Ltd. (Bristol, UK). NF449 (4,4 ′,4″,4 ′
188 ″-[carbonylbis(imino-5,1,3-benzenetriyl-bis(carbonylimino))]
189 tetrakis-1,3-benzenedisulfonic acid) was purchased from
190 Calbiochem-Merck4Biosciences. U46619 was dissolved in
191 ethanol at 10 mM stock concentration. PPADS, suramin,
192 αβ-meATP, ATP, ADP, UTP, NF449, MRS2179, MRS2768
193 and substance P were dissolved in distilled water. DUP 697,
194 XAC, MRS2578 and SCH58261 were dissolved in DMSO at
195 10 mM stock concentration.
196 Data analysis
197 The contractions to ATP,αβ-meATP and UTPwere measured
198 from the stabilised U46619-induced response and were
199 expressed in grams, while the relaxations to ATP and ADP
200 were expressed as a percentage of the U46619-induced con-
201 traction. Data were expressed as log concentration–response
202 plots. Values for all figures refer to mean ± standard error of
203 the meanQ1 (SEM) with 95 % confidence. Results were com-
204 pared by one- or two-way ANOVAwith Bonferroni’s post hoc
205 test or unpaired Student’s t test (Prism, GraphPad, San Diego,
206 CA, USA). Differences were considered to be significant
207 when the P value was <0.05. N expresses the number of
208 animals.
209 Results
210 Effect of purine and pyrimidine nucleotides on vascular tone
211 in porcine-isolated pancreatic arteries
212 To investigate the effect of purine and pyrimidine nucleotide
213 agonists on porcine pancreatic arteries, αβ-meATP (10 nM to
214 100 μM), ATP (1 μM to 10 mM), UTP (10 μM to 1 mM),
215 ADP (1 μM to 1 mM) and MRS2768 (100 nM to 30 μM)
216 were applied after preconstriction with U46619. The re-
217 sponses to ATP and αβ-meATP were found to be desensitised
218 rapidly. Therefore, they were applied at single concentrations
219 (one concentration per tissue segment). The responses to UTP,
220 ADP and MRS2768 did not desensitise rapidly; thus, cumu-
221 lative concentration–response curves were generated. ATP,
222 αβ-meATP, UTP and MRS2768 induced concentration-
223 dependent contraction with a potency order of αβ-meATP >
224 MRS2768 > ATP ≥ UTP (P <0.001, two-way ANOVA;
225 Fig. 1a). The response to ATP was biphasic, since its contrac-
226 tion was followed by a relaxation (Fig. 1b) which was
227 equipotent to the concentration-dependent relaxation pro-
228 duced by ADP (Fig. 1a). The efficacies of ATP and αβ-
229meATP in inducing contraction were similar and greater than
230those of UTP orMRS2768. The relaxation to ADP and ATP at
231the highest concentration of the agonists used (1 mM) was
232similar at 4.5±0.5 g (n =10) and 5.5±0.2 g (n =7), respective-
233ly; there was no significant difference between these re-
234sponses (Fig. 1a). UTP, MRS2768 and αβ-meATP did not
235elicit vasorelaxation.
236Characterisation of responses to ATP and αβ-meATP
237in U46619-preconstricted porcine-isolated pancreatic
238arteries
239& Effect of suramin, PPADS and αβ-meATP
240Responses to ATP and αβ-meATP were characterised
241using the non-selective P2 receptor antagonists, suramin
242(100μM) and PPADS (10μM). Both suramin and PPADS
243significantly attenuated the contractions evoked by ATP
244(1 mM) and αβ-meATP (1 μM) (Fig. 2a, b). These con-
245centrations of ATP and αβ-meATP were chosen since
246they produced robust and submaximal responses, and for
247αβ-meATP, the concentration was close to the half max-
248imal effective concentration Q2(EC50) value [mean EC50
249value was 1.6 μM (95 % confidence interval (CI), 1.05
250to 2.53μM; n =8; Fig. 1a)]. The relaxation to ATPwas not
251affected by suramin or PPADS (Fig. 2c). Since αβ-
252meATP induces desensitisation of P2X receptors more
Fig. 1 a Concentration-dependent contraction of ATP, αβ-meATP, UTP
andMRS2768, a selective P2Y2 agonist, and relaxation of ADP and ATP
in U46619-preconstricted porcine pancreatic arteries (n =7–12). b Typi-
cal trace showing the biphasic response to ATP (contraction followed by
relaxation). Data are presented as mean ± SEM
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253 readily than ATP because it is broken down more slowly
254 than ATP [5], the responses to ATP and αβ-meATP were
255 studied in the presence of αβ-meATP, in which αβ-
256 meATP (1 μM) was added 10 min prior the addition of
257 U46619. As seen in Fig. 2a, b, the contractions to ATP and
258 αβ-meATP were reduced in the presence of the
259desensitising agent, while the relaxation to ATP was not
260affected (Fig. 2c).
261& Effect of NF449, a selective P2X1 receptor antagonist
262Contractile responses toαβ-meATP suggest an expres-
263sion of P2X1 receptors in porcine pancreatic arteries
264(Fig. 2b). In turn, the involvement of P2X1 receptors in
265contraction to ATP seems likely because contraction was
266significantly blocked by αβ-meATP (Fig. 2a). The re-
267sponses to ATP and αβ-meATP were studied further in
268the presence of NF449 (10 μM), a P2X1 receptor-
269selective antagonist. The contractions to ATP and αβ-
270meATP were inhibited in the presence of NF449 (Fig. 3).
271& Effect of endothelium removal
272The response to ATP was tested after the endothelium
273had been removed. The contraction and the relaxation
274induced by ATP (Fig. 4) were statistically not significantly
275different in the absence or presence of the endothelium.
276Similarly, removal of the endothelium had no effects on
277the contractions to KCl, U46619 or αβ-meATP; for ex-
278ample, the contraction to 75 mM KCl was 9.5±0.5 g in
279endothelium-intact arteries, while it was 9±0.5 g in
280endothelium-denuded arteries (n =7-9). The contraction
Fig. 2 Effect of suramin (100 μM), PPADS (10 μM) and desensitisation
by αβ-meATP (1 μM) on contractions to a ATP (1 mM) and b αβ-
meATP (1 μM) and c on the relaxation to ATP in U46619-preconstricted
porcine pancreatic arteries. PPADS, suramin and αβ-meATP reduced the
contractions of a ATP and b αβ-meATP (**P<0.01; ***P<0.001, one-
way ANOVAwith Bonferroni’s post hoc test, responses of ATP or αβ-
meATP vs their responses in the presence of PPADS, suramin or αβ-
meATP, n =6–9). c The relaxation to ATP was not significantly different
in the absence or presence of PPADS, suramin or αβ-meATP (n=7).
Data are presented as mean ± SEM
Fig. 3 Effect of NF449 (10 μM), a selective P2X1 receptor antagonist,
on contractions to a ATP (1 mM) and b αβ-meATP (1 μM), in U46619-
preconstricted porcine pancreatic arteries. NF449 reduced the effects of a
ATP and b αβ-meATP (***P<0.001, unpaired Student’s t test, n =10–
13). Data are presented as mean ± SEM
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281 to 10–100 nM U46619 was 5.5±0.5 g in endothelium-
282 intact arteries, while it was 5.8±0.6 g in endothelium-
283 denuded arteries (n =12–14). The contraction to 1 μM
284 αβ-meATP was 3.2±0.6 g in endothelium-intact arteries,
285 while it was 3±0.6 g in endothelium-denuded arteries (n =
286 6); there was no significant difference between these
287 responses.
288 & Effect of XAC, an adenosine receptor antagonist
289 The relaxation to ATP was investigated in the presence
290 of a non-selective adenosine receptor antagonist; XAC
291 (10 μM) had no effect on the contraction evoked by
292 ATP (Fig. 5a), while it reduced significantly the relaxation
293 to ATP (Fig. 5b).
294 Characterisation of response to UTP in U46619-
295 preconstricted porcine-isolated pancreatic arteries
296 & Effect of suramin, PPADS, αβ-meATP and MRS2578, a
297 selective P2Y6 receptor antagonist
298 The contraction to UTP was examined in the presence
299 of suramin (100 μM), PPADS (10 μM), αβ-meATP
300(1 μM) and MRS2578 (10 μM). Suramin and PPADS
301significantly reduced the contraction to UTP (Fig. 6),
302while the UTP responses were not affected after P2X
303receptor desensitisation in the presence of αβ-meATP
304(1 μM) or in the presence of a selective P2Y6 receptor
305antagonist (MRS2578); for example, the contraction to
3061 mM UTP was 1.8±0.2 g in the absence of MRS2578
307(n =7), while it was 2.1±0.2 g in the presence of
Fig. 4 Effect of removal of the endothelium on a contraction and b
relaxation to ATP (1 mM) in U46619-preconstricted porcine pancreatic
arteries. The effect of the removal of endothelium on the contraction or
relaxation of ATP was not significantly different (n =9–11). Data are
presented as mean ± SEM
Fig. 5 Effect of XAC (10 μM) on a contraction and b relaxation to ATP
(1 mM) in U46619-preconstricted porcine pancreatic arteries. a XAC had
no effect on the contraction to ATP (n =8–10), and b XAC reduced the
relaxation to ATP (***P <0.001, unpaired Student’s t test, n =8–10).
Data are presented as mean ± SEM
Fig. 6 Effect of suramin (100 μM) and PPADS (10 μM) on contraction to
UTP in U46619-preconstricted porcine pancreatic arteries. With suramin
and PPADS, effect of UTP concentration (F=16.77 and F=12.38, respec-
tively, ***P<0.001), suramin and PPADS reduced the contraction evoked
by UTP (F=14.47 and F=12.48, respectively, ***P<0.001, two-way
ANOVA; n=9–12). Data are presented as mean ± SEM
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308 MRS2578 (n =6); there was no significant difference be-
309 tween these responses.
310 & Effect of endothelium removal
311 The effects of UTP were studied after the endothelium
312 had been removed. The contraction induced by UTP was
313 significantly attenuated in the endothelium-denuded arter-
314 ies (Fig. 7).
315 & Effect of DUP 697, a cyclooxygenase-2 inhibitor
316 Because the contraction to UTP was largely
317 endothelium-dependent, the contraction was studied in
318 the presence of DUP 697, a cyclooxygenase-2 (COX-2)
319 inhibitor, since COX-2 facilitates the release of agents
320 which are responsible for endothelium-dependent contrac-
321 tion. DUP 697 (3 μM) diminished the response to UTP
322 (Fig. 8) to a similar extent as removal of the endothelium
323 (Fig. 7), while DUP 697 did not alter the contraction to
324 U46619 (the preconstriction agent) or the contraction to
325 ATP (data not shown).
326 Characterisation of response to ADP in U46619-
327 preconstricted porcine-isolated pancreatic arteries
328 & Effect of MRS2179, a P2Y1 receptor selective antagonist,
329 and of endothelium removal
330 The relaxation to ADP in pancreatic arteries was stud-
331 ied in the presence of MRS2179 (10 μM) and after the
332 endothelium had been removed. The relaxation to ADP
333 was reduced slightly but significantly in the presence of
334 MRS2179 (Fig. 9a) and in the endothelium-denuded ar-
335 teries (Fig. 9b), which indicates the involvement of P2Y1
336 receptors and the endothelium in ADP-mediated relaxa-
337 tion of porcine pancreatic arteries.
338 & Effect of XAC, an adenosine receptor antagonist, and
339 SCH58261, a selective adenosine A2A receptor antagonist
340 The relaxation to ADP was investigated in the presence
341 of XAC (10 μM). The relaxation to ADP was largely
342reduced in the presence of this inhibitor which indicates
343the involvement of adenosine receptors (Fig. 10). To find
344out about the adenosine subtype involved in the relaxation
345to ADP, the response to ADP was investigated in the
346presence of SCH58261, a selective adenosine A2A recep-
347tor antagonist. This antagonist significantly inhibited the
348relaxation to ADP, to a similar extent as seen with XAC
Fig. 7 Effect of removal of the endothelium on contraction to UTP in
U46619-preconstricted porcine pancreatic arteries. Effect of UTP con-
centration (F=11.91, ***P<0.001) and removal of endothelium reduced
the contraction evoked by UTP (F =43, ***P<0.001, two-way ANOVA;
n =10–12). Data are presented as mean ± SEM
Fig. 8 Effect of DUP 679 (3 μM), a cyclooxygenase-2 inhibitor, on
contraction to UTP in U46619-preconstricted porcine pancreatic arteries.
Effect of UTP concentration (F =8.48, ***P <0.001) and DUP 679
reduced the contraction evoked by UTP (F=50.8, ***P <0.001, two-
way ANOVA; n =8–12). Data are presented as mean ± SEM
Fig. 9 Effect of a MRS2179 (10 μM) and b the removal of the endo-
thelium on relaxation to ADP in U46619-preconstricted porcine pancre-
atic arteries. With MRS2179 and in endothelium-denuded arteries, effect
of ADP concentration (F =21.42 and 16.77, respectively, ***P <0.001)
and MRS2179 and removal of endothelium reduced the contraction
evoked by ADP (F =21.42 and F=32.04, respectively, ***P <0.001,
two-way ANOVA; n=10–12). Data are presented as mean ± SEM
Purinergic Signalling
JrnlID 11302_ArtID 9403_Proof# 1 - 12/11/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
349 (Fig. 10). This showed that the relaxation to ADP involved
350 A2A adenosine receptors.
351 Discussion
352 The current report has provided evidence for the functional
353 expression of contractile P2X1, P2Y2 and P2Y4 receptors and
354 vasorelaxant P2Y1 and A2A adenosine receptors in porcine
355 pancreatic arteries. These receptors are sensitive to the extra-
356 cellular nucleotides ATP (P2X1), UTP (P2Y2 and P2Y4) and
357 ADP (P2Y1 and A2A). The contraction to ATP was endothe-
358 lium independent, while UTP induced an endothelium-
359 dependent contraction which may involve P2Y2 and/or
360 P2Y4 receptors. The relaxation to ADP involved the endothe-
361 lium and P2Y1 receptors and A2A adenosine receptors.
362 A vasoconstrictor response elicited by ATP has been re-
363 ported in a number of different arteries [21–23]. ATPmay also
364 induce vasorelaxation depending on the experimental condi-
365 tions (level of pre-tone) and relative expression of relevant
366 vasocontractile and vasorelaxant receptors [24, 25]. In porcine
367 pancreatic arteries, ATP induced a biphasic response
368 consisting of a contraction followed by a relaxation
369 (Fig. 1b). Since the contraction to ATP was rapidly
370 desensitising, non-cumulative concentration–response curves
371 were investigated. The contractions to ATP and αβ-meATP
372 were reduced in the presence of suramin, PPADS, αβ-meATP
373 (a desensitiser of P2X1 receptors) and NF449 (a P2X1 selec-
374 tive antagonist) (Figs. 2a, b and 3a, b), which indicates that a
375 large part of the contraction to ATP could be attributed to the
376 activation of P2X1 receptors. Moreover, the contractile effect
377 of αβ-meATP is consistent with the expression of P2X1
378 receptors in porcine pancreatic arteries. αβ-meATP was more
379 potent than ATP in eliciting vasoconstriction most likely due
380to its greater stability [5]. Since the contraction to ATP was not
381changed after the endothelium had been removed (Fig. 4a),
382the expression of P2X1 receptors was shown to be on the
383vascular smooth muscle cells (VSMCs). This is consistent
384with the abundant expression of P2X1 receptors on VSMCs
385of most tissues [7].
386ATP-induced vasorelaxation was not affected after the
387endothelium had been removed or in the presence of suramin
388or PPADS, which suggests that the relaxation to ATP was not
389due to its action at P2Y receptors. However, the relaxation to
390ATP was significantly inhibited in the presence of XAC,
391which suggested an involvement of adenosine receptors
392expressed on VSMCs of the pancreatic arteries; it is likely
393that this is due to the activity of adenosine derived from ATP
394metabolism by ecto-nucleotidase 5 ′- tr iphosphate
395diphosphohydrolase (ENTPDase) enzymes followed by the
396activity of CD37 and ecto-5′-nucleotidase enzymes [26]. Sim-
397ilarly, in rat coronary arteries, the relaxation to ATP involved
398P1 receptors, although there was an additional involvement of
399P2Y receptors [24]. In the current study, further investigation
400of the adenosine receptor subtypes involved in the relaxation
401to ATP is required. We and others have shown previously a
402slow relaxation in response to αβ-meATP in rat mesenteric
403arteries, subsequent to contraction [27–29], but we did not
404observe this in the present study in the porcine pancreatic
405arteries.
406The vasoconstriction to UTP did not desensitise quickly;
407therefore, cumulative concentration–response curves were
408used to study the effect of UTP on pancreatic arteries. This
409contraction was significantly inhibited by suramin and
410PPADS (Fig. 6), and there was a reduction of the response
411after the removal of the endothelium (Fig. 7). That would
412indicate for the first time an endothelium-dependent vasocon-
413striction evoked by UTP. UTP is known to be active at P2Y2,
414P2Y4 and P2Y6 receptors [30]. The expression of these recep-
415tors in the endothelium and smoothmuscle of vessels has been
416reported [31]. Since MRS2578 was not able to alter the
417contraction to UTP, this indicates that UTP had no action at
418P2Y6 receptors. There are currently no commercially available
419selective antagonists for either P2Y2 or P2Y4 receptors. How-
420ever, we believe that UTP acted at P2Y4 receptors since the
421contraction to UTP was significantly inhibited by both endo-
422thelium removal and in the presence of DUP 697, but re-
423sponses to ATP were unaffected. UTP-induced contraction
424may also be mediated by P2Y2 receptors, since MRS2768
425which is a selective agonist at P2Y2 receptors and displays no
426affinity for P2Y4 or P2Y6 receptors was able to evoke a
427contraction in pancreatic arteries [32] (Fig. 1a).
428UTP-induced vasoconstriction has been documented in a
429number of arteries including rat pulmonary arteries in which
430the contraction was attributed to P2Y2 receptors, and in rabbit
431basilar arteries in which the contraction to UTP was due to
432action of P2Y4 receptors [33, 34]. UTP produced an
Fig. 10 Effect of XAC (10 μM), a non-selective adenosine receptor
antagonist, and SCH58261 (1 μM), a selective adenosine A2A receptor
antagonist, on relaxation to ADP in U46619-preconstricted porcine pan-
creatic arteries. With XAC and SCH58261, effect of ADP concentrations
(F =7.14 and F=6.08, respectively, ***P <0.001), XAC and SCH58261
reduced the relaxation evoked by ADP (F =71.19 and F=58.16, respec-
tively, ***P <0.001, two-way ANOVA; n =9–14). Data are presented as
mean ± SEM
Purinergic Signalling
JrnlID 11302_ArtID 9403_Proof# 1 - 12/11/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
433 endothelium-dependent relaxation in rabbit pulmonary arter-
434 ies and in rat mesenteric arterial bed, but the receptor subtypes
435 were undefined [22, 35]. In bovine middle cerebral arterial
436 strips, UTP had a dual response, and it induced a contraction
437 in endothelium-denuded arteries, but a relaxation in
438 endothelium-intact arteries [36]. The absence of
439 endothelium-dependent or endothelium-independent relaxa-
440 tion to UTP and some other nucleotides in rat renal arteries
441 was reported [37], which is consistent with the current study
442 since there was no evidence of a UTP-mediated relaxation in
443 porcine pancreatic arteries. Hence, porcine pancreatic arteries
444 appear not to express relaxant P2Y2 and/or P2Y4 receptors.
445 To investigate the mechanism underlying the contraction
446 mediated by UTP in pancreatic arteries, the response to UTP
447 was examined in the presence of DUP 697. As seen in Fig. 8,
448 the endothelium-dependent contraction was attenuated in the
449 presence of the selective COX-2 inhibitor. Endothelial cells
450 can release endothelium-derived contractile factors (EDCFs),
451 which may include thromboxane A2, prostaglandin F2α, leu-
452 kotrienes and endothelin-1. Thromboxane A2 and prostaglan-
453 din F2α are released from the endothelium due to the activity
454 of COX-2 [38, 39]. The reduction of the contraction to UTP in
455 the presence of DUP 697 indicated the involvement of throm-
456 boxane A2 and prostaglandins in the contraction to UTP.
457 These agents, after being released from the endothelium,
458 may act on their receptors on VSMCs to cause contraction
459 [39]. The different effects of DUP 697 on responses to UTP
460 and ATP further suggest that they are acting on different
461 receptors.
462 The relaxation to ADP did not desensitise rapidly; there-
463 fore, cumulative concentration–response curves were used to
464 study the effect of ADP on pancreatic arteries. The relaxation
465 was significantly attenuated by MRS2179, a selective P2Y1
466 receptor antagonist (Fig. 9a). In addition, the relaxation to
467 ADP was reduced after the endothelium had been removed,
468 by a similar extent as observed in the presence of the
469 MRS2179 (Fig. 9b). This may suggest that P2Y1 receptors
470 are expressed on the endothelium. Indeed, a number of reports
471 show that P2Y1 receptors are expressed on the endothelium
472 and are responsible for the relaxation of arteries, including rat
473 thoracic aortic and porcine mesenteric arteries [40, 41]. The
474 relaxation to ADP in our study was largely reduced in the
475 presence of XAC and SCH58261 (adenosine receptor antag-
476 onists). Adenosine receptors may be expressed on the endo-
477 thelium or the vascular smooth muscle [42]. Since XAC and
478 SCH58261 produced a greater reduction in the relaxation to
479 ADP than the inhibition induced by removal of the endothe-
480 lium (Fig. 10), this suggests that relaxation to ADP involves
481 A2A adenosine receptors expressed, at least in part, on
482 VSMCs. The mechanism by which ADP would produce
483 adenosine to act at the adenosine receptors is still to be
484 elucidated. The simplest explanation is that it is broken down
485 by ENTPDases and by CD37 enzymes to adenosine [26].
486Alternatively, as suggested in porcine coronary arteries,
487ADP mediates a relaxation via a mechanism that involves
488ADP-evoked adenosine release and the subsequent activation
489of A2A receptors [20]. In contrast to the porcine pancreatic
490vessels, ADP in rat pancreatic arteries induced a contraction at
491a high concentration (1 mM); this contraction was similar to
492that produced by ATP and was much lower than the contrac-
493tion induced by αβ-meATP [43]. Further investigation is
494required to determine the involvement of endothelium-
495derived relaxing factors or endothelium-derived
496hyperpolarising factors released from the endothelium in the
497ADP-induced relaxation.
498Reduction in pancreatic blood flow has been observed in
499acute and chronic pancreatitis and some other pancreatic
500diseases [44, 45], implicating pancreatic tissue perfusion as
501an important factor in the pathogenesis of pancreatic diseases
502and symptoms. There is increasing evidence for the role of
503purinergic signalling in the pathophysiology of the pancreas
504[2]. Hence, drugs designed to target specific components of
505purinergic system may be of relevance to the management of
506pancreatitis, cystic fibrosis, pancreatic cancer and diabetes.
507In summary, the functional expression of P2X1 and A2A
508adenosine receptors on VSMCs and P2Y2 and/or P2Y4 recep-
509tors on the endothelium of porcine pancreatic arteries was
510indicated in the current study. Activation of P2X1 receptors
511by ATP or αβ-meATP induced a vasoconstriction, and UTP
512acts at P2Y2 and/or P2Y4 receptors to induce a contraction.
513ADP and ATP activate A2A adenosine receptors to induce
514relaxation, together with an action of ADP on P2Y1 receptors.
515Pancreatic arteries appear to lack vasorelaxant P2Y2 and/or
516P2Y4 receptors.
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